PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma

PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma

Background: Recently, increasing evidence has indicated that platelet-activating factor acetylhydrolase 1b catalytic subunit 3 (PAFAH1B3) plays an important role in several cancers. However, its role in lung adenocarcinoma (LUAD) has not been reported until now. Methods: The expression of PAFAH1B3 i...

Full description

Bibliographic Details
Main Authors: Chen, B. (Author), Huang, J. (Author), Ni, J. (Author), Ni, S. (Author), Sun, F. (Author), Tang, S. (Author), Tang, Z. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
EMT
Immune infiltrates
LUAD
PAFAH1B3
Prognosis
Online Access:View Fulltext in Publisher

Similar Items

Similar Items